APA (7th ed.) Citation

Yang, C., Xuan, T., Gong, Q., Dai, X., Wang, C., Zhang, R., . . . Li, J. (2024). Efficacy and safety of novel immune checkpoint inhibitor‐based combinations versus chemotherapy as first‐line treatment for patients with extensive‐stage small cell lung cancer. Thoracic Cancer, 15(15), 1246. https://doi.org/10.1111/1759-7714.15310

Chicago Style (17th ed.) Citation

Yang, Chuang, et al. "Efficacy and Safety of Novel Immune Checkpoint Inhibitor‐based Combinations Versus Chemotherapy as First‐line Treatment for Patients with Extensive‐stage Small Cell Lung Cancer." Thoracic Cancer 15, no. 15 (2024): 1246. https://doi.org/10.1111/1759-7714.15310.

MLA (9th ed.) Citation

Yang, Chuang, et al. "Efficacy and Safety of Novel Immune Checkpoint Inhibitor‐based Combinations Versus Chemotherapy as First‐line Treatment for Patients with Extensive‐stage Small Cell Lung Cancer." Thoracic Cancer, vol. 15, no. 15, 2024, p. 1246, https://doi.org/10.1111/1759-7714.15310.